Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 5/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.38 |
| ▸ | CDK9 | P50750 | 2/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL914644 | 0.98 | EGFR (0.46) | EGFRPOLBNPY5RTSHRPPARD | |
| SCHEMBL915629 | 0.95 | ESR1 (0.48) | EGFRPOLBNPY5RTSHRPPARD | |
| SCHEMBL915420 | 0.95 | EGFR (0.44) | EGFRPOLBNPY5RTSHRPPARD | |
| SCHEMBL915403 | 0.92 | LTA4H (0.51) | EGFRPOLBESR1ESR2PTPN1 | |
| SCHEMBL915687 | 0.90 | NR1H2 (0.44) | EGFRPOLBNPY5RTSHRPPARD | |
| SCHEMBL914846 | 0.90 | MAPT (0.47) | EGFRPOLBNPY5RTSHRESR1 | |
| SCHEMBL3375825 | 0.90 | TSHR (0.50) | EGFRPOLBNPY5RTSHRPPARD | |
| SCHEMBL916528 | 0.89 | GAA (0.46) | EGFRPOLBNPY5RESR1CA12 | |
| SCHEMBL2239195 | 0.89 | ESR1 (0.43) | EGFRTSHRESR1LTA4HKDM4E | |
| SCHEMBL916542 | 0.89 | ESR1 (0.48) | EGFRPOLBNPY5RTSHRESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250298333-A1 | POLYESTER RESIN COMPOSITION, ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, DEVELOPER, AND IMAGE FORMING METHOD | Konica Minolta, Inc. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250099494-A1 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | HAIHE BIOPHARMA CO., LTD. (CN) | 2025-03-27 | — | — | US | disclosed |
| EP-4467552-A1 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | Haihe Biopharma Co., Ltd. (CN) | 2024-11-27 | — | — | EP | disclosed |
| WO-2023243634-A1 | TRANSFER SHEET | 日東電工株式会社 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023243636-A1 | MEMBER PROCESSING METHOD | 日東電工株式会社 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023138637-A1 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | 上海海和药物研究开发股份有限公司 | 2023-07-27 | — | — | WO | disclosed |
| WO-2023061999-A1 | PROCESS FOR PREPARING A PHENOLIC HYDROCARBON | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023061999-A1 | PROCESS FOR PREPARING A PHENOLIC HYDROCARBON | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2023-04-20 | — | — | WO | disclosed |
| EP-4166531-A1 | PROCESS FOR PREPARING A PHENOLIC HYDROCARBON | Studiengesellschaft Kohle mbH (DE) | 2023-04-19 | — | — | EP | disclosed |
| US-20220213126-A1 | SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES | JOHN WAYNE CANCER INSTITUTE (US) | 2022-07-07 | — | — | US | disclosed |
| EP-1400549-A1 | POLYMERIZATION CATALYST FOR POLYESTER, POLYESTER PRODUCED WITH THE SAME, AND PROCESS FOR PRODUCING POLYESTER | Toyo Boseki Kabushiki Kaisha (JP) | 2004-03-24 | — | — | EP | disclosed |
| EP-1206472-B1 | OXAZOLE AND THIAZOLE DERIVATIVES AS NEUROTROPHIN PRODUCTION/SECRETION PROMOTING AGENT | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-6605629-B1 | Oxazole derivatives; low toxicity | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20030083191-A1 | Polyester polymerization catalyst, polyester produced by using the same, and process for producing polyester | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2003-05-01 | — | — | US | disclosed |
| CN-1090621-C | Process for preparing quinazolin-4-one derivatives | OTSUKA PHARMA CO LTD (JP) | 2002-09-11 | — | — | CN | disclosed |
| EP-1206472-A1 | OXAZOLE AND THIAZOLE DERIVATIVES AS NEUROTROPHIN PRODUCTION/SECRETION PROMOTING AGENT | Takeda Chemical Industries, Ltd. (JP) | 2002-05-22 | — | — | EP | disclosed |
| WO-2001014372-A2 | OXAZOLE AND THIAZOLE DERIVATIVES AS NEUROTROPHIN PRODUCTION/SECRETION PROMOTING AGENT | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-03-01 | — | — | WO | disclosed |
| US-6107284-A | Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments | PIERRE FABRE MEDICAMENT (FR) | 2000-08-22 | — | — | US | disclosed |
| CN-1193967-A | Process for producing quinazoline-4-one derivatives | OTSUKA PHARMA CO LTD (US) | 1998-09-23 | — | — | CN | disclosed |
| US-4059615-A | INSECTICIDE, POLYMER INTERMEDIATE | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213126-A1 | SMALL MOLECULE AUTOPHAGY INDUCERS FOR THE TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES | TFEB, SQSTM1, BECN1 | EGFR 2004/4885POLB 3083/4885NPY5R 4336/4885 |
| US-20250099494-A1 | PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF, AND PREPARATION METHODS FOR AND USES OF PHOSPHONIC ACID COMPOUND AND PRODRUG THEREOF | ENPP1, ENPP3, PPA1 | EGFR 1844/4885POLB 2608/4885NPY5R 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.